Back to results
UnknownPhase 3

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

NCT05673629

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fudan University Shanghai Cancer Center

Shanghai, China

Contact

RONGGUO QIU, PhD

01186-56315388rqiu2001@yahoo.com
View on ClinicalTrials.gov
Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer — TrialFind